I've been trying to wrap my head around the concept of what is fair for the GNBT shareholders regarding ownership of NIO. At first I thought that since GNBT shareholders own all of NIO/AE now, then if it is spun off to a separate company and then we only own 10%, then we are gypped. And it is possible that after enough time the market would realize the worth of NIO even without the spinoff.

But then, I decided that I needed to look at it in a similar way to how the 4 guys who put their shares in the GNBT share pool are looking at it. For the good of the company, they are opting to wait and have a smaller share of hopefully a gigantic thing, rather than a big share of a small thing. I think the same concept applies to us with NIO. By spinning it off, we will have a smaller share of hopefully a much more gigantic thing. And it may bring a big pharma buyer much sooner and for much more money.